Kyu Sang Lee
Overview
Explore the profile of Kyu Sang Lee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
65
Citations
651
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim J, Na H, Lee S, Kim J, Suh K, Kim S, et al.
Sci Rep
. 2025 Jan;
15(1):2171.
PMID: 39820489
Next-generation sequencing (NGS) cancer profiling has gained traction in routine clinical practice in South Korea. Here, we evaluated the use of NGS testing and genomically-matched therapies for patients with advanced...
2.
Jang H, Moon S, Kwon H, Lee S, Choe G, Lee K
Hum Pathol
. 2024 Dec;
154:105709.
PMID: 39701425
Diffuse midline gliomas with H3 K27-alteration (DMGH3) are lethal and inoperable brain tumors. Although DMGH3s mainly occur in pediatric patients, they have also occurred in adult patients. This study aimed...
3.
Lee J, Moon S, Kwon H, Lee S, Choe G, Lee K
Urol Oncol
. 2024 Sep;
42(12):454.e21-454.e30.
PMID: 39341712
Purpose: Clear cell renal cell carcinoma (ccRCC) often harbors Polybromo 1 (PBRM1) alterations. These alterations are associated with immune checkpoint blockade response in ccRCC, particularly antiprogrammed cell death 1 (PD1)/programmed...
4.
Lee Y, Chowdhury T, Kim S, Yu H, Kim K, Kang H, et al.
Exp Mol Med
. 2024 Apr;
56(4):975-986.
PMID: 38609519
We explored the genomic events underlying central neurocytoma (CN), a rare neoplasm of the central nervous system, via multiomics approaches, including whole-exome sequencing, bulk and single-nuclei RNA sequencing, and methylation...
5.
Lee K, Choi E, Cho S, Park S, Ryu J, Puche A, et al.
Histopathology
. 2024 Mar;
85(1):81-91.
PMID: 38477366
Aims: Immune checkpoint inhibitors targeting programmed death-ligand 1 (PD-L1) have shown promising clinical outcomes in urothelial carcinoma (UC). The combined positive score (CPS) quantifies PD-L1 22C3 expression in UC, but...
6.
Park S, Kim C, Lee K, Hwang S, Piao Y
Nanoscale
. 2023 Aug;
15(34):14155-14164.
PMID: 37592918
Developing a facile strategy which enhances the structural stability and air/moisture stability of transition metal phosphides for practical applications is important but challenging. Herein, we designed a densely packed free-standing...
7.
Oh S, Nam S, Lee K, Lee H, Park Y, Kwak Y, et al.
Cancer Res Treat
. 2023 Aug;
56(1):219-237.
PMID: 37591783
Purpose: Bone metastasis (BM) adversely affects the prognosis of gastric cancer (GC). We investigated molecular features and immune microenvironment that characterize GC with BM compared to GC without BM. Materials...
8.
Kim K, Lee K, Cho S, Kang D, Park S, Kang Y, et al.
Med Image Anal
. 2023 Jul;
89:102886.
PMID: 37494811
Microsatellite instability (MSI) refers to alterations in the length of simple repetitive genomic sequences. MSI status serves as a prognostic and predictive factor in colorectal cancer. The MSI-high status is...
9.
Cho Y, Lee K, Piao S, Kim T, Kang S, Park S, et al.
RSC Adv
. 2023 Feb;
13(7):4656-4668.
PMID: 36760306
Silicon microparticles (SiMPs) show considerable promise as an anode material in high-performance lithium-ion batteries (LIBs) because of their low-cost starting material and high capacity. The failure issues associated with the...
10.
Um M, Lee E, Lee J, Lee K, Kang Y, Ahn J, et al.
Taehan Yongsang Uihakhoe Chi
. 2022 Oct;
82(3):700-707.
PMID: 36238793
Hemangioblastomas are low-grade, highly vascular tumors that are usually associated with von Hippel-Lindau syndrome. Hemangioblastomas most commonly occur in the cerebellum, and intradural extramedullary hemangioblastoma of the cauda equina is...